Evaluable population (n = 36) | ITT population (n = 49) | |||
---|---|---|---|---|
No. | % | No. | % | |
Complete response | 3 | 8 | 3 | 6 |
Partial response | 10 | 28 | 11 | 22 |
Minor response | 7 | 19 | 7 | 14 |
Stable disease | 9 | 25 | 10 | 20 |
Progressive disease | 7 | 19 | 8 | 16 |
Not evaluable* | - | - | 10 | 20 |
Overall response rate (95% CI), % | 36 (21–54) | 29 (16–42) | ||
Median duration of response (95% CI), months | 10.4 (5.9–11.1) | 10.4 (4.5–11.1) | ||
Median duration of stabilisation (95% CI), months | 5.8 (4.0–8.3) | 6.4 (4.0–8.3) | ||
Median time to progression (95% CI), months | 7.0 (4.5–10.1) | 5.9 (4.0–8.1) | ||
Median time of survival (range), months | - | 12.0 (8.0–15.2) |